Skip to content

C-reactive protein-albumin-lymphocyte index and coronary microvascular dysfunction after primary percutaneous coronary intervention: The mediating role of insulin resistance.

Oct 2026 · International Journal of Cardiology · pp. 135001 · 0 citations · 30 references
Medicine

Abstract

Background

The C-reactive protein-albumin-lymphocyte (CALLY) index integrates systemic inflammation, nutritional status, and immune function. We investigated its association with angiography-derived microvascular resistance (AMR)-defined coronary microvascular dysfunction (CMD) in patients with ST-segment elevation myocardial infarction (STEMI) undergoing primary percutaneous coronary intervention (PCI), and performed an exploratory statistical mediation analysis involving estimated glucose disposal rate (eGDR).

Methods

This retrospective, single-center observational study included 456 consecutive patients with STEMI undergoing primary PCI. AMR-defined CMD was prespecified as AMR ≥250 mmHg·s/m. Multivariable logistic regression, restricted cubic spline (RCS), and prespecified subgroup analyses were performed. Sensitivity and exploratory mediation analyses were also performed.

Results

AMR-defined CMD was present in 228 patients (50.0%). In Model 3, each doubling of CALLY was associated with lower odds of AMR-defined CMD (OR, 0.87; 95% CI, 0.80-0.94; P < 0.001). Compared with Q1, Q3 and Q4 were associated with 44% (OR, 0.56; 95% CI, 0.32-0.97; P = 0.037) and 52% (OR, 0.48; 95% CI, 0.28-0.84; P = 0.010) lower odds, respectively (P for trend = 0.018). RCS analysis showed an overall association (P = 0.001) without evidence of nonlinearity (P = 0.310). No significant subgroup interactions were observed. Exploratory mediation analysis estimated that eGDR statistically accounted for 15.47% of the observed association.

Conclusions

Higher CALLY values were inversely associated with AMR-defined CMD after primary PCI for STEMI. eGDR may account for part of this association. CALLY may serve as an auxiliary marker for AMR-defined CMD risk stratification, pending prospective multicenter validation.

View source

We use cookies to run the site and, with your consent, for analytics and to show ads. See our Cookie Policy.